Together we can change the future of biologics.
Join us on our journey.

Join Our Team

Work alongside those who are similarly driven to provide critical medicine for countless patients in need.

Vice President, Quality Assurance

Xentria is a patient-centric biotech company focused on novel biologics and biosimilars. Our first program is XT MAB 16, a monoclonal antibody for sarcoidosis. XT MAB 16 has received Orphan Drug Designation. The Vice President, Quality Assurance is responsible for overseeing and directing the development, implementation and maintenance of quality management practices and systems as governed by GCP, GMP and GLP (GxP) regulations, to ensure compliance with internal policies, business objectives, procedures, and external regulations and standards.

Read More

This website uses cookies

We use cookies to improve your experience on our site. You can read more about our Cookie Policy in our Privacy policy.

Allow cookies Reject cookies